Logo image of BGM

BGM GROUP LTD (BGM) Stock Price, Forecast & Analysis

USA - Nasdaq - NASDAQ:BGM - KYG7307E1237 - Common Stock

3.88 USD
+0.4 (+11.49%)
Last: 1/6/2026, 6:40:32 PM

BGM Key Statistics, Chart & Performance

Key Statistics
Market Cap630.34M
Revenue(TTM)26.85M
Net Income(TTM)-2.72M
Shares162.46M
Float51.75M
52 Week High17.17
52 Week Low3.25
Yearly DividendN/A
Dividend Yield0%
EPS(TTM)-0.28
PEN/A
Fwd PEN/A
Earnings (Next)N/A N/A
IPO2021-01-12
Sector
GICS SectorHealth Care
GICS IndustryPharmaceuticals
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryPharmaceuticals


BGM short term performance overview.The bars show the price performance of BGM in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months -10 -20 -30 -40 -50

BGM long term performance overview.The bars show the price performance of BGM in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60

The current stock price of BGM is 3.88 USD. In the past month the price decreased by -44.57%. In the past year, price decreased by -65.81%.

BGM GROUP LTD / BGM Daily stock chart

BGM Competitors/Peers

The largest stocks on the US markets in the "Pharmaceuticals" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
LLY ELI LILLY & CO 48.39 1.01T
JNJ JOHNSON & JOHNSON 19.73 493.40B
MRK MERCK & CO. INC. 12.36 270.22B
PFE PFIZER INC 7.95 144.59B
BMY BRISTOL-MYERS SQUIBB CO 8.3 110.79B
ZTS ZOETIS INC 20.4 57.00B
RPRX ROYALTY PHARMA PLC- CL A 9.89 23.46B
VTRS VIATRIS INC 5.32 14.28B
ELAN ELANCO ANIMAL HEALTH INC 24.79 11.83B
AXSM AXSOME THERAPEUTICS INC N/A 8.66B
BLTE BELITE BIO INC - ADR N/A 5.59B
CRNX CRINETICS PHARMACEUTICALS IN N/A 4.36B

About BGM

Company Profile

BGM logo image BGM Group Ltd. is a holding company, which engages in the technology fields of AI application, intelligent robots, algorithmic computing power, cloud computing, and biopharmaceuticals. The company is headquartered in Chengdu, Sichuan and currently employs 323 full-time employees. The company went IPO on 2021-01-12. The firm operates through three segments: Oxytetracycline & Licorice Products and TCMD segment, Fertilizer segment and Heparin Products and Sausage Casing segment. The firm's main brand is Qilian Shan. The firm principally operates its businesses within the domestic market.

Company Info

BGM GROUP LTD

No. 152 Hongliang East 1st Street, No. 1703, Tianfu New District

Chengdu SICHUAN CN

Employees: 323

BGM Company Website

BGM Investor Relations

Phone: 862864775180

BGM GROUP LTD / BGM FAQ

Can you describe the business of BGM GROUP LTD?

BGM Group Ltd. is a holding company, which engages in the technology fields of AI application, intelligent robots, algorithmic computing power, cloud computing, and biopharmaceuticals. The company is headquartered in Chengdu, Sichuan and currently employs 323 full-time employees. The company went IPO on 2021-01-12. The firm operates through three segments: Oxytetracycline & Licorice Products and TCMD segment, Fertilizer segment and Heparin Products and Sausage Casing segment. The firm's main brand is Qilian Shan. The firm principally operates its businesses within the domestic market.


Can you provide the latest stock price for BGM GROUP LTD?

The current stock price of BGM is 3.88 USD. The price increased by 11.49% in the last trading session.


What is the dividend status of BGM GROUP LTD?

BGM does not pay a dividend.


How is the ChartMill rating for BGM GROUP LTD?

BGM has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 2 out of 10.


Where is BGM GROUP LTD (BGM) stock traded?

BGM stock is listed on the Nasdaq exchange.


What is the market capitalization of BGM stock?

BGM GROUP LTD (BGM) has a market capitalization of 630.34M USD. This makes BGM a Small Cap stock.


Can you provide the ownership details for BGM stock?

You can find the ownership structure of BGM GROUP LTD (BGM) on the Ownership tab.


BGM Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating

BGM Fundamental Analysis

ChartMill assigns a fundamental rating of 2 / 10 to BGM. BGM scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

BGM Financial Highlights

Over the last trailing twelve months BGM reported a non-GAAP Earnings per Share(EPS) of -0.28. The EPS increased by 74.4% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -1.31%
ROE -1.49%
Debt/Equity 0.01
Chartmill High Growth Momentum
EPS Q2Q%-146.9%
Sales Q2Q%13.92%
EPS 1Y (TTM)74.4%
Revenue 1Y (TTM)-10.12%

BGM Forecast & Estimates


Analysts
AnalystsN/A
Price TargetN/A
EPS Next YN/A
Revenue Next YearN/A

BGM Ownership

Ownership
Inst Owners0.2%
Ins Owners25.02%
Short Float %0.15%
Short Ratio4.06